These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 31434683)

  • 41. Comparative efficacy of different treatment modalities in the management of pediatric non-alcoholic fatty liver disease: A systematic review and network meta-analysis.
    Theodoridis X; Kalopitas G; Vadarlis A; Bakaloudi DR; Gkiourtzis Ν; Dionysopoulos G; Karanika E; Tsekitsidi E; Chourdakis M
    Pharmacol Ther; 2022 Dec; 240():108294. PubMed ID: 36183848
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of acupoint therapy on nonalcoholic fatty liver disease: A systematic review and meta-analysis.
    Bi Y; Yin B; Fan G; Xia Y; Huang J; Li A; Lin Y
    Complement Ther Clin Pract; 2021 May; 43():101376. PubMed ID: 33813176
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: A meta-analysis.
    Katsagoni CN; Georgoulis M; Papatheodoridis GV; Panagiotakos DB; Kontogianni MD
    Metabolism; 2017 Mar; 68():119-132. PubMed ID: 28183444
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and safety of glucagon-like peptide-1 receptor agonists in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Dong Y; Lv Q; Li S; Wu Y; Li L; Li J; Zhang F; Sun X; Tong N
    Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):284-295. PubMed ID: 28065744
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of vitamin D supplementation on metabolic profiles and liver function in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Tabrizi R; Moosazadeh M; Lankarani KB; Akbari M; Heydari ST; Kolahdooz F; Samimi M; Asemi Z
    Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S975-S982. PubMed ID: 28751149
    [TBL] [Abstract][Full Text] [Related]  

  • 46. NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs.
    Caldwell S
    Clin Mol Hepatol; 2017 Jun; 23(2):103-108. PubMed ID: 28494529
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Liraglutide in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials.
    Kalogirou MS; Patoulias D; Haidich AB; Akriviadis E; Sinakos E
    Clin Res Hepatol Gastroenterol; 2021 May; 45(3):101568. PubMed ID: 33309563
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Statins for the Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: A Systematic Review and Meta-Analysis.
    Dai W; Xu B; Li P; Weng J
    Am J Ther; 2023 Jan-Feb 01; 30(1):e17-e25. PubMed ID: 36608070
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects and Safety of Sitagliptin in Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Zhang Y; Cai T; Zhao J; Guo C; Yao J; Gao P; Dong J; Liao L
    Horm Metab Res; 2020 Jul; 52(7):517-526. PubMed ID: 32559768
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease.
    Musso G; Gambino R; Cassader M; Pagano G
    Hepatology; 2010 Jul; 52(1):79-104. PubMed ID: 20578268
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of HuoXueHuaYu therapy for nonalcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trial.
    Cai Y; Liang Q; Chen W; Chen M; Chen R; Zhang Y; Xiao Y; Chen L
    BMC Complement Altern Med; 2019 Jul; 19(1):178. PubMed ID: 31324247
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of pharmacological interventions and placebo on liver Histology in nonalcoholic steatohepatitis: A network meta-analysis.
    Pennisi G; Celsa C; Enea M; Vaccaro M; Di Marco V; Ciccioli C; Infantino G; La Mantia C; Parisi S; Vernuccio F; Craxì A; Cammà C; Petta S
    Nutr Metab Cardiovasc Dis; 2022 Oct; 32(10):2279-2288. PubMed ID: 35970684
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of nutraceuticals for the treatment of non-alcoholic fatty liver disease.
    Del Ben M; Polimeni L; Baratta F; Pastori D; Angelico F
    Br J Clin Pharmacol; 2017 Jan; 83(1):88-95. PubMed ID: 26852185
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of silymarin plus vitamin E in patients with non-alcoholic fatty liver disease. A randomized clinical pilot study.
    Aller R; Izaola O; Gómez S; Tafur C; González G; Berroa E; Mora N; González JM; de Luis DA
    Eur Rev Med Pharmacol Sci; 2015 Aug; 19(16):3118-24. PubMed ID: 26367736
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacological interventions for non-alcoholic fatty liver disease: a systematic review and network meta-analysis.
    Sridharan K; Sivaramakrishnan G; Sequeira RP; Elamin A
    Postgrad Med J; 2018 Oct; 94(1116):556-565. PubMed ID: 30341231
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of non-alcoholic steatohepatitis patients with vitamin D: a double-blinded, randomized, placebo-controlled pilot study.
    Geier A; Eichinger M; Stirnimann G; Semela D; Tay F; Seifert B; Tschopp O; Bantel H; Jahn D; Marques Maggio E; Saleh L; Bischoff-Ferrari HA; Müllhaupt B; Dufour JF
    Scand J Gastroenterol; 2018 Sep; 53(9):1114-1120. PubMed ID: 30270688
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Current and Potential Future Pharmacological Approaches for Non- Alcoholic Fatty Liver Disease.
    Imprialos K; Stavropoulos K; Bouloukou S; Kerpiniotis G; Karagiannis A; Doumas M
    Curr Vasc Pharmacol; 2018; 16(3):276-288. PubMed ID: 28676020
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of vitamin E in nonalcoholic fatty liver disease with metabolic syndrome: A propensity score-matched cohort study.
    Kim GH; Chung JW; Lee JH; Ok KS; Jang ES; Kim J; Shin CM; Park YS; Hwang JH; Jeong SH; Kim N; Lee DH; Kim JW
    Clin Mol Hepatol; 2015 Dec; 21(4):379-86. PubMed ID: 26770927
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Randomized, vitamin E-controlled trial of bicyclol plus metformin in non-alcoholic fatty liver disease patients with impaired fasting glucose.
    Han Y; Shi JP; Ma AL; Xu Y; Ding XD; Fan JG
    Clin Drug Investig; 2014 Jan; 34(1):1-7. PubMed ID: 24081374
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Xiaoyao Powder in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Liu N; Yang J; Ma W; Li C; An L; Zhang X; Zou Q
    J Ethnopharmacol; 2022 Apr; 288():114999. PubMed ID: 35051605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.